StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA Premarket Approvals (PMA & Supplements) — Medtronic

U.S. FDA openFDA Device PMA Endpoint (Mapped to Medtronic April FY)

QuarterlyAnnualMonthly
Latest, Q1 FY27
114
Period ended Jul 31, 2026
Change on a year earlier
-22.4%
147 in Q1 FY26
History
51 quarters
Since Q3 FY14
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA Premarket Approvals (PMA & Supplements) — MedtronicYear on yearSource
Q1 FY27Jul 31, 2026114-22.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26Apr 30, 2026168+30.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26Jan 31, 202693-41.5%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26Oct 31, 2025135+42.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26Jul 31, 2025147+22.5%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25Apr 30, 2025129-2.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25Jan 31, 2025159+8.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25Oct 31, 202495-31.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25Jul 31, 2024120-3.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24Apr 30, 2024132+36.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24Jan 31, 2024147+40.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24Oct 31, 2023139+13.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24Jul 31, 2023124-13.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23Apr 30, 202397-43.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23Jan 31, 2023105-33.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23Oct 31, 2022122+3.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Breakdown

What makes up fda premarket approvals (pma & supplements) — medtronic

Cite this data

StockData. (2026). Medtronic FDA Premarket Approvals (PMA & Supplements) — Medtronic, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-pma-co

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.